All Stories

  1. National trends in incidence, prevalence and disability-adjusted life years of invasive aspergillosis in Iran: a systematic review and meta-analysis
  2. MGL_3741 gene contributes to pathogenicity of Malassezia globosa in pityriasis versicolor
  3. Estimated burden of serious human fungal diseases in Turkey
  4. Emerging Aspergillus Species Almost Exclusively Associated With Primary Immunodeficiencies
  5. Corrigendum: Fungal infections in animals: a patchwork of different situations
  6. Genetic Diversity and Antifungal Susceptibility of Candida parapsilosis Sensu Stricto Isolated from Bloodstream Infections in Turkish Patients
  7. Genetic diversity and antifungal susceptibility of Candida albicans isolated from Iranian patients
  8. Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung
  9. Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis
  10. Fungal infections in animals: a patchwork of different situations
  11. Predominance of non- fumigatus Aspergillus species among patients suspected to pulmonary aspergillosis in a tropical and subtropical region of the Middle East
  12. Overview of selected virulence attributes in Aspergillus fumigatus , Candida albicans , Cryptococcus neoformans , Trichophyton rubrum , and Exophiala dermatitidis
  13. Biofilm Formation and Resistance to Fungicides in Clinically Relevant Members of the Fungal Genus Fusarium
  14. Aspergillus fumigatus alkaline protease 1 (Alp1/ Asp f13 ) in the airways correlates with asthma severity
  15. Defective calcineurin/NFAT signaling in myeloid cells and susceptibility to aspergillosis in post-transplant patients
  16. Absent in vitro interaction between chloroquine and antifungals against Aspergillus fumigatus
  17. Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis
  18. Successful treatment of azole-resistant invasive aspergillosis in a bottlenose dolphin with high-dose posaconazole
  19. In Vivo Efficacy of Liposomal Amphotericin B against Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates in Two Different Immunosuppression Models of Invasive Aspergillosis
  20. Genetic Diversity and In Vitro Antifungal Susceptibility of 200 Clinical and Environmental Aspergillus flavus Isolates
  21. Azole Resistance in Aspergillus fumigatus: Mechanisms, Route of Resistance Selection, and Clinical Implications
  22. In Vitro Antifungal Susceptibility Profiles of 12 Antifungal Drugs against 55 Trichophyton schoenleinii Isolates from Tinea Capitis Favosa Patients in Iran, Turkey, and China
  23. Topical and systemic antifungals in dermatology practice
  24. Systemic Antifungal Agents: Current Status and Projected Future Developments
  25. Aspergillus flavus Keratitis: Experience of a Tertiary Eye Clinic in Turkey
  26. Pharmacodynamics of Voriconazole against Wild-Type and Azole-Resistant Aspergillus flavus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis
  27. Discrimination of Aspergillosis, Mucormycosis, Fusariosis, and Scedosporiosis in Formalin-Fixed Paraffin-Embedded Tissue Specimens by Use of Multiple Real-Time Quantitative PCR Assays
  28. Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections
  29. Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India
  30. Conventional Morphology Versus PCR Sequencing, rep-PCR, and MALDI-TOF-MS for Identification of ClinicalAspergillusIsolates Collected Over a 2-Year Period in a University Hospital at Kayseri, Turkey
  31. Combination of Amphotericin B and Flucytosine against Neurotropic Species of Melanized Fungi Causing Primary Cerebral Phaeohyphomycosis
  32. A 9-Month-Old Girl from Iran with Extensive Erythematous Plaques Due to Trichophyton simii, a Zoophilic Dermatophyte
  33. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses
  34. Infrequent Production of Xanthomegnin by Fungal Strains Recovered from Patients with Ocular Mycoses
  35. Pharmacodynamics of Ceftazidime and Avibactam in Neutropenic Mice with Thigh or Lung Infection
  36. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014
  37. Dermatophytosis due to Microsporum incurvatum: Notification and Identification of a Neglected Pathogenic Species
  38. ATR-FTIR Spectroscopy Highlights the Problem of Distinguishing Between Exophiala dermatitidis and E. phaeomuriformis Using MALDI-TOF MS
  39. Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran
  40. Clinical and Laboratory Features of Six Cases of Candida and Dermatophyte Folliculitis and a Review of Published Studies
  41. Aspergillusand aspergilloses in wild and domestic animals: a global health concern with parallels to human disease
  42. Epidemiological changes in tinea capitis over the sixty years of economic growth in China
  43. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus
  44. Emergence of fusarioses in a university hospital in Turkey during a 20-year period
  45. Neglected fungal zoonoses: hidden threats to man and animals
  46. Comparison of theIn VitroActivities of Newer Triazoles and Established Antifungal Agents against Trichophyton rubrum
  47. Plasma and Epithelial Lining Fluid Pharmacokinetics of Ceftolozane and Tazobactam Alone and in Combination in Mice
  48. Pharmacodynamics of Isavuconazole in an Aspergillus fumigatus Mouse Infection Model
  49. Pharmacokinetics and Penetration of Ceftazidime and Avibactam into Epithelial Lining Fluid in Thigh- and Lung-Infected Mice
  50. Azole Resistance in Aspergillus fumigatus: Mechanisms, Route of Resistance Selection, and Clinical Implications
  51. Candida ve Kandidoz: Epidemiyoloji, Tanı, Tedavi, Antifungal İlaç Direnci ve Konağın Genetik Yatkınlığında Güncel Durum
  52. Posaconazole Prophylaxis in Experimental Azole-Resistant Invasive Pulmonary Aspergillosis
  53. In vitro antifungal susceptibility of Trichophyton violaceum isolated from tinea capitis patients
  54. Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases
  55. The role of azoles in the management of azole-resistant aspergillosis: From the bench to the bedside
  56. Black Yeasts and Their Filamentous Relatives: Principles of Pathogenesis and Host Defense
  57. Effects of Low-Level Laser Irradiation on the Pathogenicity ofCandida albicans:In Vitro and in VivoStudy
  58. Antifungal Susceptibility Patterns of Opportunistic Fungi in the Genera Verruconis and Ochroconis
  59. Intrapulmonary Posaconazole Penetration at the Infection Site in an Immunosuppressed Murine Model of Invasive Pulmonary Aspergillosis Receiving Oral Prophylactic Regimens
  60. Continuous Infusion of Amphotericin B Deoxycholate for the Treatment of Life-ThreateningCandidaInfections
  61. Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis
  62. Azole-ResistantAspergillus fumigatus, Iran
  63. Pharmacodynamics and Dose-Response Relationships of Liposomal Amphotericin B against Different Azole-Resistant Aspergillus fumigatus Isolates in a Murine Model of Disseminated Aspergillosis
  64. Phaeohyphomycoses, Emerging Opportunistic Diseases in Animals
  65. In Vitro Interaction of Voriconazole and Anidulafungin against Triazole-Resistant Aspergillus fumigatus
  66. Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis
  67. Pharmacodynamics of Anidulafungin against Clinical Aspergillus fumigatus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis
  68. Multiple subcutaneous cysts due toExophiala spiniferain an immunocompetent patient
  69. Waterborne Exophiala species causing disease in cold-blooded animals
  70. Assessment of efficacy of antifungals in experimental models of invasive aspergillosis in an era of emerging resistance: the value of real-time quantitative PCR
  71. Exophiala sideris, a novel black yeast isolated from environments polluted with toxic alkyl benzenes and arsenic